Is Tirzepatide FDA Approved?

Yes, tirzepatide is FDA approved in the United States, but only as a brand-name prescription medicine. The FDA has approved tirzepatide as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management, with an added approval for obstructive sleep apnea. Compounded tirzepatide sold by some pharmacies and online sellers is not FDA-approved.

Is Tirzepatide FDA-Approved? The Short Answer

Tirzepatide is a dual GIP and GLP-1 receptor agonist manufactured by Eli Lilly. Every FDA-approved version of the drug is a Lilly-made injectable product dispensed by prescription.

The key distinction is that FDA approval applies to specific products for specific uses, not to a molecule in general. A pharmacy-compounded "tirzepatide" product is not the same as Mounjaro or Zepbound, and it has never gone through the agency's new drug review.

What Is Tirzepatide Approved For?

The FDA has cleared tirzepatide for three separate indications under two brand names. Each approval came with its own clinical trial data and prescribing information.

Mounjaro for Type 2 Diabetes

Mounjaro was approved in May 2022 to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. In June 2024, the FDA extended that approval to children 10 years and older with type 2 diabetes.

Zepbound for Weight Management and Sleep Apnea

Zepbound was approved in November 2023 for adults with a body mass index of 30 or higher, or a BMI of 27 or higher with a weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. In December 2024, the FDA added moderate-to-severe obstructive sleep apnea in adults with obesity. Zepbound is intended for long-term use with a reduced-calorie diet and more physical activity.

Is Compounded Tirzepatide FDA-Approved?

No. The FDA does not approve compounded drugs the way it approves new brand-name medications, and compounded tirzepatide has never been reviewed or authorized by the agency.

Compounding is legal in narrow situations, such as when a patient needs a dose or ingredient that isn't commercially available. The FDA declared the tirzepatide shortage resolved in December 2024, which removed the main pathway that allowed large-scale compounding of the drug and set compliance deadlines for 503A and 503B pharmacies.

Anyone asking is compound tirzepatide safe should know that these products are not FDA-approved and have not been evaluated for potency, sterility, or purity. Independent testing has found some compounded vials with incorrect doses or unexpected contaminants.

What FDA Approval Does and Does Not Mean

• It means the drug was reviewed: the manufacturer submitted clinical trial data on safety, effectiveness, dosing, and manufacturing quality.
• It means the label is regulated: approved products carry prescribing information with dosing, warnings, and drug interactions.
• It does not mean risk-free: common side effects include nausea, vomiting, diarrhea, constipation, and fatigue. Serious risks include pancreatitis, gallbladder disease, and a boxed warning about thyroid C-cell tumors observed in rodents.
• It does not mean a cure: tirzepatide is used for ongoing management, and weight often returns if the medication stops without other lifestyle changes.

How Tirzepatide Compares With Semaglutide

Both are prescription GLP-1-based medicines, but they are not identical. If you are checking whether is semaglutide fda-approved, the answer is yes — it is approved as Ozempic, Rybelsus, and Wegovy for different indications.

The question tirzepatide vs semaglutide which is better for weight loss was tested head-to-head in the SURMOUNT-5 trial, which compared the two drugs at their maximum tolerated doses in adults with obesity.

Results from a single trial do not predict what will happen for any one person, and tolerability often matters as much as the average number. Tirzepatide is not FDA-approved for cosmetic weight loss in people who do not meet the label criteria.

Dosing, Units, and Other Common Questions

Approved tirzepatide comes in fixed-dose pens delivering 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg once weekly, along with single-dose vials. Treatment always starts at 2.5 mg and increases slowly to limit side effects.

A question like how many mg is 50 units of tirzepatide only has an answer when you know the concentration printed on the label of that specific vial. "Units" measure volume on an insulin-style syringe rather than the amount of drug, so the same number of units can mean very different doses from one product to another.

The same principle applies to research peptides: the answer to is cjc-1295 ipamorelin fda approved is no, and products sold under that name are not approved medicines no matter what a website claims.

Bottom Line

Tirzepatide is FDA approved as Mounjaro and Zepbound for specific medical conditions. Compounded tirzepatide is not FDA approved and carries extra uncertainty about dose and purity.

If you are considering tirzepatide, talk with a licensed healthcare professional who can review your history, discuss side effects and costs, and prescribe an approved product when it is appropriate for you.